Revolution MedicinesRVMD
13F holders, Q2 2026 (June 30)693holders +179
237new positions
61sold out
10famous investors
$187.58avg. 13F price*
At the end of Q2 2026, 693 institutions reported holding Revolution Medicines Inc. (RVMD) in their 13F filings, up 179 from Q1 2026. 237 opened new positions and 61 sold out. The largest holders were BlackRock, Inc. ($2.6B), Farallon Capital Management, L.L.C. ($2.5B) and FMR LLC ($2.3B). 10 famous investors held it, including Stanley Druckenmiller (1.7% of Duquesne Family Office's portfolio), Cliff Asness (0.1% of AQR Capital Management's portfolio) and Ken Griffin (0.1% of Citadel Advisors's portfolio).
- Company
- Revolution Medicines Inc.
- CUSIP
- 76155X100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 237 | $1.8B |
| Exits | 61 | $297.0M |
All 13F filers, Q1 2026 → Q2 2026: 44,106,129 shares bought and 31,699,785 shares sold, net +12,406,344 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 693 holders
| BlackRock, Inc. | 0.04% | Add +22.1% | 13,695,790 | $2.6B |
| Farallon Capital Management, L.L.C. | 14.98% | Reduce -0.4% | 13,550,796 | $2.5B |
| FMR LLC | 0.10% | Add +44.1% | 12,200,422 | $2.3B |
| Baker Bros. Advisors LP | 10.78% | Add +19.8% | 11,443,357 | $2.1B |
| Darwin Global Management, Ltd. | 54.45% | Add +380.8% | 10,629,822 | $2.0B |
| Jupiter Topco LLC | 0.82% | — | 10,736,145 | $2.0B |
| Vanguard Capital Management LLC | 0.04% | Add +8.7% | 9,088,661 | $1.7B |
| Vanguard Portfolio Management LLC | 0.07% | Add +10.6% | 8,294,855 | $1.6B |
| Nextech Invest Ltd. | 67.55% | No change | 7,601,087 | $1.4B |
| Paradigm Biocapital Advisors LP | 22.31% | Reduce -4.4% | 6,361,323 | $1.2B |
| UBS Group AG | 0.16% | Add +24.2% | 5,448,364 | $1.0B |
| State Street Corp. | 0.03% | Add +11.2% | 4,897,051 | $917.1M |
| Capital World Investors | 0.09% | New | 4,008,244 | $750.7M |
| Geode Capital Management, LLC | 0.04% | Add +18.1% | 3,942,676 | $736.8M |
| Wellington Management Group LLP | 0.12% | Reduce -36.2% | 3,843,415 | $719.8M |
| JPMorgan Chase & Co. | 0.04% | Add +994.3% | 3,298,066 | $636.9M |
| BVF Inc. | 14.20% | Add +3.8% | 2,965,160 | $555.3M |
| Alphabet Inc. | 0.56% | Reduce -10.5% | 2,946,619 | $551.8M |
| Casdin Capital, LLC | 24.16% | No change | 2,577,333 | $482.7M |
| Deerfield Management Company, L.P. | 5.58% | Add +4.1% | 2,392,000 | $448.0M |
| T. Rowe Price Associates Inc. | 0.04% | Reduce -26.1% | 2,390,303 | $447.7M |
| Avoro Capital Advisors LLC | 3.86% | Reduce -2.0% | 2,297,000 | $430.2M |
| Norges Bank | 0.04% | — | 2,157,479 | $404.1M |
| Goldman Sachs Group Inc. | 0.04% | Reduce -2.4% | 2,133,101 | $399.5M |
| Nearwater Capital Markets, Ltd | 6.77% | Add +209.3% | 2,097,000 | $392.7M |
| Massachusetts Financial Services Co. | 0.12% | New | 2,012,317 | $376.8M |
| Woodline Partners LP | 1.16% | Reduce -20.1% | 2,002,863 | $375.1M |
| Caligan Partners LP | 17.73% | Add +18.7% | 1,961,795 | $367.4M |
| Charles Schwab Investment Management Inc. | 0.05% | Add +10.5% | 1,917,025 | $359.0M |
| Integral Health Asset Management, LLC | 11.53% | No change | 1,500,000 | $280.9M |
| Franklin Resources Inc. | 0.06% | Add +31.3% | 1,488,394 | $278.7M |
| Holocene Advisors, LP | 0.58% | Reduce -44.9% | 1,359,269 | $254.6M |
| AQR Capital Management | 0.08% | Add +1009.2% | 1,295,450 | $242.6M |
| Vanguard Fiduciary Trust Co. | 0.05% | Add +13.9% | 1,291,141 | $241.8M |
| Northern Trust Corp. | 0.02% | Add +17.1% | 1,117,110 | $209.2M |
| Rock Springs Capital Management LP | 10.10% | Reduce -8.6% | 1,105,210 | $207.0M |
| National Bank of Canada | 0.18% | Reduce -37.3% | 1,096,025 | $205.3M |
| Bellevue Group AG | 4.13% | Reduce -32.1% | 1,048,014 | $196.3M |
| Ameriprise Financial Inc. | 0.04% | Reduce -34.2% | 1,039,702 | $194.7M |
| Pictet Asset Management Holding SA | 0.18% | Add +82.0% | 1,014,894 | $190.8M |
| Bank of America Corp. | 0.01% | Add +60.2% | 983,911 | $184.3M |
| a16z Capital Management, L.L.C. | 1.21% | No change | 921,099 | $172.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.03% | Add +82.3% | 912,335 | $170.9M |
| Siren, L.L.C. | 3.42% | Reduce -19.0% | 900,000 | $168.6M |
| Deutsche Bank AG | 0.05% | Add +90.7% | 888,019 | $166.3M |
| Morgan Stanley | 0.01% | Add +18.8% | 838,249 | $157.0M |
| Lord, Abbett & Co. LLC | 0.44% | Add +488.0% | 789,241 | $147.8M |
| Dimensional Fund Advisors LP | 0.03% | Reduce -9.6% | 763,434 | $143.1M |
| Two Sigma Investments, LP | 0.11% | Reduce -52.7% | 737,697 | $138.2M |
| Logos Global Management LP | 5.64% | Reduce -65.0% | 700,000 | $131.1M |
| Polar Capital Holdings Plc | 0.37% | Reduce -39.1% | 690,316 | $129.3M |
| Alyeska Investment Group, L.P. | 0.32% | Reduce -65.0% | 659,279 | $123.5M |
| Bank of New York Mellon Corp | 0.02% | Reduce -5.4% | 601,056 | $112.6M |
| Westfield Capital Management Co. LP | 0.37% | Reduce -61.4% | 600,821 | $112.5M |
| Adage Capital Partners Gp, L.L.C. | 0.16% | Reduce -89.1% | 597,226 | $111.8M |
| Citadel Advisors | 0.06% | Add +47.5% | 589,906 | $110.5M |
| T. Rowe Price Investment Management, Inc. | 0.07% | Reduce -12.8% | 579,382 | $108.5M |
| Invesco Ltd. | 0.01% | Add +47.2% | 578,287 | $108.3M |
| DAFNA Capital Management LLC | 20.09% | Reduce -3.1% | 562,630 | $105.4M |
| Candriam S.C.A. | 0.47% | Reduce -4.2% | 556,392 | $104.1M |
| BNP Paribas Financial Markets | 0.05% | Add +30.8% | 552,710 | $103.5M |
| MIC Capital Management UK LLP | 25.25% | Reduce -33.2% | 531,733 | $99.6M |
| Perceptive Advisors LLC | 1.54% | Add +104.0% | 527,600 | $98.8M |
| Boxer Capital Management, LLC | 7.05% | No change | 500,000 | $93.6M |
| MPM Bioimpact LLC | 5.62% | Reduce -2.8% | 492,483 | $92.2M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 4.91% | No change | 479,080 | $89.7M |
| Nuveen, LLC | 0.02% | Add +39.5% | 475,231 | $89.0M |
| Boothbay Fund Management, LLC | 1.71% | Add +6.2% | 465,787 | $87.2M |
| Swiss National Bank | 0.04% | Add +7.3% | 456,331 | $85.5M |
| Vestal Point Capital, LP | 1.97% | Reduce -81.0% | 450,000 | $84.3M |
| First Turn Management, LLC | 8.32% | Reduce -11.3% | 415,307 | $77.8M |
| Checkpoint Capital L.P. | 19.72% | Add +56.3% | 410,353 | $76.9M |
| Duquesne Family Office | 1.72% | Add +26.5% | 399,587 | $74.8M |
| Legal & General Group Plc | 0.01% | Add +11.8% | 381,366 | $71.4M |
| General Atlantic, L.P. | 2.31% | Reduce -49.5% | 357,791 | $67.0M |
| California Public Employees Retirement System | 0.04% | Add +24.1% | 349,929 | $65.5M |
| Mass General Brigham, Inc | 17.85% | No change | 344,091 | $64.4M |
| TCG Crossover Management, LLC | 1.53% | Reduce -40.9% | 340,899 | $63.8M |
| Qube Research & Technologies Ltd | 0.07% | Reduce -43.2% | 314,365 | $58.9M |
| 1832 Asset Management L.P. | 0.07% | New | 309,200 | $57.9M |
| Sumitomo Mitsui Trust Group, Inc. | 0.03% | Add +13.0% | 306,300 | $57.4M |
| AIHC Capital Management Ltd | 54.46% | Reduce -63.4% | 303,133 | $56.8M |
| Jennison Associates LLC | 0.03% | Reduce -8.6% | 280,933 | $52.6M |
| Patient Square Capital LP | 8.01% | New | 276,000 | $51.7M |
| National Pension Service | 0.03% | New | 273,604 | $51.2M |
| Amundi | 0.01% | Add +94.7% | 269,701 | $50.5M |
| Baillie Gifford & Co. | 0.04% | Add +40.8% | 263,466 | $49.3M |
| Fred Alger Management, LLC | 0.16% | Add +1113.9% | 259,468 | $48.6M |
| Chicago Capital, LLC | 1.14% | New | 251,847 | $47.2M |
| Affinity Asset Advisors, LLC | 2.33% | Add +150.0% | 250,000 | $46.8M |
| Citigroup Inc. | 0.02% | Add +175.3% | 247,052 | $46.3M |
| Nicholas Investment Partners, LP | 2.95% | Reduce -6.3% | 244,594 | $45.8M |
| Marshall Wace, LLP | 0.04% | Add +12.9% | 244,544 | $45.8M |
| Seven Fleet Capital Management LP | 7.48% | Add +199.6% | 242,029 | $45.3M |
| California State Teachers Retirement System | 0.04% | Add +44.3% | 238,463 | $44.7M |
| Victory Capital Management Inc. | 0.02% | Add +62.0% | 230,909 | $43.2M |
| Susquehanna International Group, LLP | 0.04% | Add +343.7% | 227,985 | $42.7M |
| Eventide Asset Management, LLC | 0.57% | Reduce -12.8% | 227,845 | $42.7M |
| Royal Bank of Canada | 0.01% | Reduce -39.1% | 226,210 | $42.4M |
| Rhumbline Advisers | 0.03% | Add +25.6% | 226,008 | $42.3M |
"% of holder's portfolio" is RVMD's weight in each manager's 13F, not the share of Revolution Medicines Inc. the manager owns.